| Literature DB >> 35415358 |
Şükriye Çakmak1, Sevgi Kansiz2, Mohammad Azam3, Cem Cüneyt Ersanlı4, Önder İdil5, Aysel Veyisoğlu1, Hasan Yakan6, Halil Kütük7, Arunabhiram Chutia8.
Abstract
In this study, a novel heterocyclic amide derivative, N-(3-cyanothiophen-2-yl)-2-(thiophen-2-yl)acetamide (I), was obtained by reacting 2-aminothiophene-3-carbonitrile with activated 2-(thiophen-2-yl)acetic acid in a N-acylation reaction and characterized by elemental analyses, FT-IR, 1H and 13C NMR spectroscopic studies, and single crystal X-ray crystallography. The crystal packing of I is stabilized by C-H···N and N-H···N hydrogen bonds. In addition, I was investigated computationally using the density functional theory (DFT) method with the B3LYP exchange and correlation functions in conjunction with the 6311++G(d,p) basis set in the gas phase. Fukui function (FF) analysis was also carried out. Electrophilicity-based charge transfer (ECT) method and charge transfer (ΔN) were computed to examine the interactions between I and DNA bases (such as guanine, thymine, adenine, and cytosine). The most important contributions to the Hirshfeld surface are H···H (21%), C···H (20%), S···H (19%), N···H (14%), and O···H (12%). An ABTS antioxidant assay was used to evaluate the in vitro antioxidant activity of I. The compound exhibited moderate antioxidant activity. The antimicrobial activity of the title molecule was investigated under aseptic conditions, using the microdilution method, against Gram-positive and Gram-negative bacterial strains, and it also demonstrated significant activity against yeasts (Candida glabrata ATCC 90030, Candida krusei ATCC 34135). The findings revealed that the molecule possesses significant antioxidant and antimicrobial properties.Entities:
Year: 2022 PMID: 35415358 PMCID: PMC8992280 DOI: 10.1021/acsomega.2c00318
Source DB: PubMed Journal: ACS Omega ISSN: 2470-1343
Scheme 1Synthesis of N-(3-Cyanothiophen-2-yl)-2-(thiophen-2-yl)acetamide
Data Collection and Structure Refinement for I
| CCDC | 2132193 |
| chemical formula | C11H8N2OS2 |
| temperature (K) | 296 |
| space group | |
| crystal system | monoclinic |
| 448.31 | |
| 4.4439 (2), 22.6851 (13), 11.1242 (7) | |
| α, β, γ (deg) | 90, 96.530 (2), 90 |
| volume, | 1114.16 (11) |
| crystal size (mm) | 0.30 × 0.25 × 0.22 |
| calculated density (Mg/m3) | 1.480 |
| 512 | |
| μ (mm–1) | 0.46 |
| Z | 4 |
| diffractometer | Bruker APEX3 CCD |
| θ range (deg) | 2.6 ≤ θ ≤ 27.3 |
| wavelength (Å) | 0.71073 |
| measurement method | ω scan |
| absorption correction | Multiscan |
| –5, 5 | |
| –30, 30 | |
| –14, 14 | |
| Rint | 0.046 |
| reflections collected | 31325 |
| independent reflections | 2751 |
| observed reflections [ | 1966 |
| refinement method | SHELXL18/3 |
| parameters | 148 |
| 0.060 | |
| 0.204 | |
| GooF = | 1.06 |
| Δρmin, Δρmax (e/Å3) | –0.48, 0.84 |
Figure 1(a) Crystal structure and (b) optimized geometry of I.
Minimum Inhibition Concentrations (MIC’s) of the Tested Compound
Hydrogen Bonds of I (Å, deg)
| D | D | H···A | D···A | D | symmetry code |
|---|---|---|---|---|---|
| N1 | 0.84(2) | 2.21(2) | 3.049(4) | 172(4) | (i) − |
| C5 | 0.97 | 2.57 | 3.409(5) | 145 |
Figure 2View of crystal packing of I forming R21(6), R22(12), and R22(16) rings.
Some Geometric Parameters of I (Å, deg)
| geometric parameters | X-ray | geometric parameters | X-ray |
|---|---|---|---|
| bond lengths (Å) | bond angles (deg) | ||
| C1 | 1.702 (3) | C1 | 92.5 (2) |
| C4 | 1.688 (5) | C7 | 91.61 (17) |
| C7 | 1.723 (3) | C6 | 124.2 (3) |
| C8 | 1.718 (4) | N1 | 121.4 (3) |
| C6 | 1.217 (4) | C5 | 122.8 (3) |
| C11 | 1.142 (5) | C7 | 122.7 (3) |
| C9 | 1.429 (5) | C9 | 124.4 (3) |
| C6 | 1.370 (4) | torsion angles (deg) | |
| C7 | 1.380 (4) | S2 | –177.6 (3) |
| C10 | 1.421 (5) | S1 | –92.7 (3) |
| C1 | 1.504 (5) | N1 | 179.7 (3) |
| C5 | 1.511 (5) | C1 | –79.8 (4) |
Figure 3IR spectrum of N-(3-cyanothiophen-2-yl)-2-(thiophen-2-yl) acetamide.
Figure 41H NMR spectrum of I.
Figure 513C NMR spectrum of I.
Results of the Natural Population Analysis (NPA) for I
| atom | |||||
|---|---|---|---|---|---|
| C1 | –0.23911 | –0.19579 | –0.25123 | 0.01212 | 0.04332 |
| C2 | –0.25265 | –0.24466 | –0.30465 | 0.05200 | 0.00799 |
| C3 | –0.24474 | –0.19263 | –0.25004 | 0.00530 | 0.05211 |
| C4 | –0.37493 | –0.30184 | –0.42038 | 0.04545 | 0.07309 |
| C5 | –0.49603 | –0.51053 | –0.49164 | –0.00439 | –0.01450 |
| C6 | 0.69587 | 0.70071 | 0.61084 | 0.08503 | 0.00484 |
| C7 | 0.05599 | 0.11139 | –0.02532 | 0.08131 | 0.05540 |
| C8 | –0.39458 | –0.25352 | –0.46233 | 0.06775 | 0.14106 |
| C9 | –0.20415 | –0.17736 | –0.21147 | 0.00732 | 0.02679 |
| C10 | –0.27316 | –0.17606 | –0.33920 | 0.06604 | 0.09710 |
| C11 | 0.28127 | 0.24577 | 0.27757 | 0.00370 | –0.03550 |
| O1 | –0.60117 | –0.52799 | –0.67673 | 0.07556 | 0.07318 |
| N1 | –0.62357 | –0.55701 | –0.54771 | 0.07586 | 0.06656 |
| N2 | –0.32644 | –0.20934 | –0.44469 | 0.11825 | 0.1171 |
| S1 | 0.43262 | 0.48268 | 0.37975 | 0.05287 | 0.05006 |
| S2 | 0.50290 | 0.56078 | 0.38703 | 0.11587 | 0.05788 |
IP, EA, μ, η, ΔN, and ECT values for I
| compound and DNA bases | IP (au) | EA (au) | μ (au) | η (au) | Δ |
|---|---|---|---|---|---|
| 5.4 × 10–3 | 0.2989 | –0.15215 | –0.14675 | 1.03670 | |
| adenine | –0.01258 | 0.30519 | –0.14630 | –0.158886 | 0.92081 |
| ECT = 0.11589 | |||||
| cytosine | –0.00616 | 0.321254 | –0.15754 | –0.163709 | 0.96234 |
| ECT = 0.07436 | |||||
| guanine | –0.00214 | 0.290467 | –0.14415 | –0.146308 | 0.98531 |
| ECT = 0.05139 | |||||
| thymine | 0.076022 | 0.3631556 | –0.21958 | –0.143566 | 1.52952 |
| ECT = −0.49282 |
Figure 6Hirshfeld surface mapped with dnorm, di, de, shape index, and curvedness of I.
Figure 7Two-dimensional fingerprint plots and HS for I.
Figure 8Intermolecular interactions and their percentages in I.
Figure 9ABTS radical scavenging activity of the title compound.